Coverage dated May 5, 2025 to May 6, 2025

Dr. Vinay Prasad to head FDA vaccine, biologics division

Headline from MedicalXpress

The U.S. Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad, a professor at the University of California-San Francisco, to lead its Center for Biologics Evaluation and Research.

MedicalXpress's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Reports & sources

14 articles, oldest first.

  1. NBC News

    FDA names oncologist Dr. Vinay Prasad, a Covid vaccine critic, as the new vaccine chief (opens NBC News)

    Published

    NBC News's feed description

    The new FDA vaccine chief, Dr. Vinay Prasad was an outspoken critic of the agency's response to the pandemic, including the former vaccine chief, Dr. Peter Marks.

  2. Green Field Reporter

    Critic of drug industry and COVID-19 measures to lead FDA vaccine program - The Daily Reporter (opens Green Field Reporter)

    Published

    Green Field Reporter's feed description

    WASHINGTON (AP) — Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to oversee the health agency’s program for vaccines and biotech drugs. FDA Commissioner Dr.

  3. CBS News

    FDA picks critic of COVID boosters to be new top vaccines official (opens CBS News)

    Published

    CBS News's feed description

    Dr. Vinay Prasad replaces Dr. Peter Marks, who Prasad had called "dangerous."

  4. MyNorthwest

    Critic of drug industry and COVID-19 measures to lead FDA vaccine program (opens MyNorthwest)

    Published

    MyNorthwest's feed description

    WASHINGTON (AP) — Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to oversee the

  5. CNN

    FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division (opens CNN)

    Published

    CNN's feed description

    The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics Evaluation and Research, the division that oversees vaccines and biologic medicines.

  6. Washington Examiner

    COVID-19 booster critic tapped to lead FDA vaccine program (opens Washington Examiner)

    Published

    Washington Examiner's feed description

    FDA Commissioner Marty Makary selected Dr. Vinay Prasad, a prominent critic of COVID-19 boosters, to lead the Center for Biologics Evaluation and Research.

  7. Newsweek

    Who is Vinay Prasad? RFK Jr. taps pharma critic to lead FDA vaccine program (opens Newsweek)

    Published

    Newsweek's feed description

    Prasad's appointment marks the latest addition of a medical skeptic and critics of COVID-19 policies to federal health leadership.

  8. New York Post

    FDA names oncologist Vinay Prasad as top vaccine official (opens New York Post)

    Published

    New York Post's feed description

    The FDA has named Vinay Prasad, an oncologist who has previously criticized COVID-19 restrictions, as the director of its Center for Biologics Evaluation and Research.

  9. MedicalXpress

    Dr. Vinay Prasad to head FDA vaccine, biologics division (opens MedicalXpress)

    Published

    MedicalXpress's feed description

    The U.S. Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad, a professor at the University of California-San Francisco, to lead its Center for Biologics Evaluation and Research.

  10. New Hampshire Union Leader

    FDA names agency critic Vinay Prasad as top vaccine official (opens New Hampshire Union Leader)

    Published

    New Hampshire Union Leader's feed description

    The Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and COVID-19 mandates, as the director of its Center for Biologics Evaluation and

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

Dr. Vinay Prasad to head FDA vaccine, biologics division | Since Then